Osim Revises Product Information After CCCS Flags Misleading Claims

The Competition and Consumer Commission of Singapore (CCCS) has flagged multiple concerns regarding Osim's promotional practices and product labelling, citing potential misleading representations to consumers. The company has since taken corrective measures.

Key Issues Identified by CCCS:

1. Lack of Pre-Purchase Product Suitability Disclosure
   • Consumers could only access critical suitability information—such as restrictions for individuals with specific health conditions—after purchasing and opening the packaging.
   • Due to Osim's no-refund policy post-opening, affected customers were unable to obtain refunds.
2. Misleading Use of "Stanford Medicine" Logo
   • Osim's promotional materials featured the Stanford Medicine logo, potentially implying institutional endorsement, when in fact it was only endorsed by a medical consultant with previous lecturing experience at Stanford University.